Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
Holding CVRX?
Track your performance easily
CVRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.40 - $33.14
Previous Close$9.25
Volume128.78K
Average Volume (3M)338.78K
Market Cap
$198.25M
Enterprise Value$161.46M
Total Cash (Recent Filing)$70.40M
Total Debt (Recent Filing)$30.34M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Oct 30, 2024EPS Estimate
-$0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.57
Shares Outstanding21,785,714
10 Day Avg. Volume261,765
30 Day Avg. Volume338,777
Standard Deviation0.28
R-Squared0.05
Alpha-0.00013
Financial Highlights & Ratios
Price to Book (P/B)3.64
Price to Sales (P/S)4.26
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.64
Enterprise Value/Gross Profit4.89
Enterprise Value/Ebitda-3.14
Forecast
1Y Price Target
$16.00Price Target Upside75.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
CVRx News
PremiumCompany Announcements
CVRx Enhances Board with Strategic New AppointmentsBulls Say, Bears Say
Bulls Say
Financial PerformanceCVRX reported Q2 revenue of $11.8M, a 24% year-over-year increase, which matched both the analyst's and consensus estimates.
Market PositionGiven the size of the market and current penetration of ~2%, effectively targeting the current indication is enough to position CVRx as an attractive growth opportunity over the long-term, regardless of ultimate 2025 reimbursement.
Technology And InnovationCVRx has a novel technology with robust clinical evidence in a multi-billion-dollar market with a significant unmet need.
Bears Say
ReimbursementCMS has proposed moving Barostim back to APC 5465, reducing reimbursement to $31K.
Sales ForceSales force disruption is typically a multi-quarter overhang.
Sales PerformanceThe company’s active account base was smaller than estimated, losing one account quarter-over-quarter.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $6.40 and its highest was $33.13 in the past 12 months.
What is CVRx’s market cap?
Currently, no data Available
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Oct 30, 2024 which is in 40 days.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on Jul 29, 2024. The company reported -$0.65 earnings per share for the quarter, missing the consensus estimate of -$0.546 by -$0.104.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -$0.47.
How many shares outstanding does CVRx have?
CVRx has 21,785,713 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$0.65 in its last earnings report, missing expectations of -$0.546. Following the earnings report the stock price went down -14.563%.
Which hedge fund is a major shareholder of CVRx?
Among the largest hedge funds holding CVRx’s share is Mairs & Power Inc. It holds CVRx’s shares valued at 2M.
---
CVRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.00 (75.82% Upside)
$16.00 (75.82% Upside)
Hedge Fund Trend
Decreased
By 74.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $322.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.66%
12-Months-Change
Fundamentals
Return on Equity
-74.91%
Trailing 12-Months
Asset Growth
-16.52%
Trailing 12-Months
Company Description
CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases.
---
CVRX Earnings Call
Q2 2024
0:00 / 0:00
---
CVRX Stock 12 Month Forecast
Average Price Target
$16.00
▲(75.82% Upside)
Technical Analysis
Axonics Modulation Technologies
―
Inspire Medical Systems
―
Stereotaxis
―
Nevro Corp
―
Best Analysts Covering CVRX
1 Year
1 Year Success Rate
9/16 ratings generated profit
1 Year Average Return
+16.93%
assigned a buy rating 2 months ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +16.93% per trade.
---